• Profile
Close

Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study

Respiratory Medicine Apr 02, 2020

Wu X, Xu L, Cheng Q, et al. - Researchers assessed whether serum soluble programmed death ligand 1(sPD-L1) levels associated with the development of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Via enzyme-linked immunosorbent assay, serum sPD-L1 were assessed. sPD-L1 levels were compared in RA with ILD, RA without ILD and healthy controls. Via logistic regression analysis, correlations between ILD and various markers including sPD-L1 and confounding factors were evaluated. Diagnostic values of sPD-L1 for the presence of ILD were investigated. Applying receiver operating characteristics curve analysis, diagnostic values of sPD-L1 for the presence of ILD were analyzed. There were significant improvement of serum sPD-L1 levels in RA patients with ILD. There were an association between aIncreased sPD-L1 levels and the presence of ILD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay